Only strongly enhanced residual FDG uptake in early response PET (Deauville 5 or qPET ≥ 2) is prognostic in pediatric Hodgkin lymphoma: Results of the GPOH-HD2002 trial.

Lars KurchD HasencleverR KlugeT GeorgiL TchavdarovaM GolombeckO SabriA EggertW BrennerK W SykoraF M BengelClaudia RossigD KörholzM SchäfersT FeuchtingerP BartensteinR A AmmannT KrauseC UrbanR AignerS GattenlöhnerW KlapperC Mauz-Körholz

Published in: Pediatric blood & cancer (2018)

Only strongly enhanced residual FDG uptake in early response PET (vDS 5 or qPET ≥ 2, respectively) seems to be markedly prognostic in PHL when treatment according to the GPOH-HD-2002 protocol is given.

Keyphrases

pet ct
positron emission tomography
pet imaging
hodgkin lymphoma
computed tomography
randomized controlled trial
study protocol
clinical trial
phase ii
combination therapy